Novartis to open new Regional R&D center in Budapest

Swiss-owned Novartis expands its Hungarian presence by adding a regional R&D center.

Apart from its core research functions, the facility will play a crucial role in coordinating related activities in several countries.

Having a tradition of over 250 years, the establishment of Novartis’ Hungarian operation dates back to the early nineties. As part of its structural optimization, the Swiss-owned corporation now strengthens its presence by setting up a regional R&D center in Budapest.

Novartis Hungária Kft. is already conducting 65 active clinical researches in the country in collaboration with numerous universities, research institutes and 19 hospitals. The new facility aims to enhance the role of the Hungarian operation as it will become responsible for coordinating clinical research activities in more than 12 countries and will also significantly increase its headcount bringing new highly skilled jobs to Hungary.

The ambitious plans require pushing up headcount in the R&D section as well. The fact that more clinical research will take place in Hungary has many benefits. Among others, Hungarian patients gain access to new medical solutions, whereas doctors can also benefit professionally. New capacities are thus created in Hungary thanks to Novartis’ commitment to implement large-scale developments in the field of data sciences, technologies and innovative research methods.